PRECISE BIO CORNEA
Precise Bio is the first company to transplant a 3D-printed cornea graft in animals. This alternative to donor tissue is designed to achieve superior quality, higher cell density, better transparency, and improved mechanical properties.
PRECISE BIOOPHTHALMOLOGY PIPELINE
The robust technology platform and promising printed human cornea program is advancing the development of other tissues and solutions for use in ophthalmic indications.
PRECISE BIO PLATFORM
Precise Bio puts existing tissue engineering science into the hands of the clinicians with the first integrated 3D printing and tissue-engineering platform to produce scalable, repeatable bio-fabricated organs from the patients’ own cells.
PRECISE BIO OPHTHALMOLOGY PIPELINE
EYE ON THE FUTURE
As a leading company in the ocular tissue engineering space, the Precise Bio Ophthalmology business unit is uniquely positioned to leverage opportunities and advance the use of bio-fabricated tissues in the field. Using our platform, we are in various stages of ongoing R&D for additional ophthalmic applications that support printing various layers with cells. These applications involve collaboration with third parties.
PRECISE BIO RETINAL PATCH
Targeted treatment for Age-related Macular Degeneration (AMD)
VISION CORRECTION LENTICULES
Offering a new approach to solve refractive errors
OCULAR SURFACE DISORDERS
Targeting various conditions involving damaged cornea surface or Limbal Stem Cell Deficiency